Fish oil is a component of SMOFLIPID, which was FDA approved in July 2016. It is indicated in adults as a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
...
Under FDA approval, fish oil pharmaceuticals are typically products consisting of a combination of the omega-3-fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and are indicated primarily as an adjunct to diet to reduce triglyceride levels in adult patients with severe (>=500 mg/dL) hypertriglyceridemia .
...
Department of Cardiology, Aalborg Hospital, Aalborg, Denmark
Childrens's Hospital Boston, Boston, Massachusetts, United States
Royal Perth Hospital, Perth, Western Australia, Australia
Royal Melbourne hospital, Melbourne, Victoria, Australia
Royal Melbourne hospital, Melbourne, Victoria, Australia
Royal Melbourne Hospital, Melbourne, Victoria, Australia
The Ponce de Leon Ctr. CRS, Atlanta, Georgia, United States
Case CRS, Cleveland, Ohio, United States
Ucsf Aids Crs, San Francisco, California, United States
Rheumatology and Internal Medicine Associates of West County, PC, St. Louis, Missouri, United States
Geisinger Medical Center, Danville, Pennsylvania, United States
UAB Arthritis Clinical Intervention Program, Birmingham, Alabama, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.